Spire Healthcare Group (LON:SPI) Trading Up 14.1% - Should You Buy?

Key Points

• Spire Healthcare Group's stock surged 14.1% to GBX 247 ($3.33) during trading, with an impressive volume increase of 563% from its average session.
• Research firms including Berenberg Bank rated Spire with a "buy" and set a target price of GBX 280, while JPMorgan Chase lowered their target to GBX 303.
• The company reported earnings of GBX 4.10 per share for the latest quarter, with an annual projected earnings per share of approximately 15.66.

Spire Healthcare Group plc (LON:SPI - Get Free Report) traded up 14.1% during mid-day trading on Saturday . The company traded as high as GBX 256.50 ($3.47) and last traded at GBX 247 ($3.34). 9,747,062 shares traded hands during mid-day trading, an increase of 563% from the average session volume of 1,469,073 shares. The stock had previously closed at GBX 216.50 ($2.93).

Analyst Upgrades and Downgrades

SPI has been the topic of a number of research analyst reports. Berenberg Bank reissued a "buy" rating and set a GBX 280 price objective on shares of Spire Healthcare Group in a report on Thursday, July 31st. JPMorgan Chase & Co. cut their price objective on Spire Healthcare Group from GBX 309 to GBX 303 and set an "overweight" rating on the stock in a report on Tuesday, August 5th. Three equities research analysts have rated the stock with a Buy rating, According to MarketBeat, the stock has an average rating of "Buy" and an average target price of GBX 294.33.

Spire Healthcare Group Stock Performance

The stock has a market capitalization of £947.58 million, a price-to-earnings ratio of 5,119.57, a price-to-earnings-growth ratio of 1.06 and a beta of 0.96. The firm has a fifty day moving average of GBX 218.99 and a 200 day moving average of GBX 203.96. The company has a debt-to-equity ratio of 62.25, a current ratio of 0.70 and a quick ratio of 0.74.

Spire Healthcare Group (LON:SPI - Get Free Report) last posted its earnings results on Thursday, July 31st. The company reported GBX 4.10 EPS for the quarter. Spire Healthcare Group had a return on equity of 3.82% and a net margin of 1.96%. On average, sell-side analysts anticipate that Spire Healthcare Group plc will post 15.6634747 earnings per share for the current fiscal year.

About Spire Healthcare Group

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.